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Although most nanofabrication techniques can control nano/micro particle (NMP) size over a wide range,
the majority of NMPs for biomedical applications exhibits a diameter of ,100 nm. Here, the vascular
distribution of spherical particles, from 10 to 1,000 nm in diameter, is studied using intravital microscopy
and computational modeling. Small NMPs (#100 nm) are observed to move with Red Blood Cells (RBCs),
presenting an uniform radial distribution and limited near-wall accumulation. Larger NMPs tend to
preferentially accumulate nexttothe vesselwalls,inasize-dependentmanner (,70%for 1,000 nm NMPs).
RBC-NMP geometrical interference only is responsible for this behavior. In a capillary flow, the effective
radial dispersion coefficient of 1,000 nm particles is ,3-fold larger than Brownian diffusion. This suggests
thatsub-micronparticlescoulddepositwithindiseasedvasculardistrictsmoreefficientlythanconventional
nanoparticles.
O
verthelast20years,aplethoraofnano/microparticles(NMPs)havebeenengineered,characterizedand
developedfortheearlydetection,imagingandtreatmentofcancerandotherdiseases
1,2.Thesecarriersof
therapeutic and imaging agents are sufficiently small to be systemically injected and transported by the
blood flow, and can virtually reach any vascular district and tissue within the body. Different NMP sizes, surface
properties and shape combinations – the 3S parameters in the design of NMPs – have been tested with the
objective of improving the delivery efficiency, that is to say the percentage of injected agents carried at the
biological target as compared to the original, total administrated dose. This has led to developing NMPs with
acharacteristicsizerangingfromafewnanometers,asinthecaseofdendrimers
3,uptoafewmicrometers
4,5;with
a surface charge varying from negative to positive and neutral, as for NMPs decorated with poly(ethylene glycol)
(PEG) chains
6,7. More recently, the NMP shape has been recognized as a critical determinant in regulating i) the
vascular transport
8,9; ii) cellular uptake
10,11 and iii) differential organ accumulation
12. Thus, in addition to the
spherical shape, cylindrical, hemispherical and discoidal NMPs are being investigated
12–15. Despite all this, the
percentage of injected NMPs accumulating at the biological target is still unsatisfactory low.
Systemically injected particles have to overcome a complex series of biological barriers before reaching their
target
16,17. From the site of administration, these barriers include i) the transport within the blood vessels where
NMPs interact with several circulating cells, including the most abundant red blood cells (RBCs); ii) the sequest-
rationbycirculatingmonocytesandmacrophagesresidingintheliverandspleen;andiii)thediffusionacrossthe
intricate tumor matrix while seeking abnormal cells. Each of these barriers reduces the NMP dose eventually
reachingthebiologicaltargetbyunspecificsequestrationandhijacking
18.Theuseofstealthcoatings,suchasPEG
chains, has increased significantly the average circulation times of NMPs, from minutes up to several hours, by
providing atemporary shieldagainstmacrophage recognition anduptake
6.Sufficiently smallNMPs,exhibiting a
characteristic size up to a few tens of nanometers (, 50 nm), such as dendrimers and micelles, have been shown
to penetrate hundreds of microns deep into the tumor tissue
19,20, as well as in organs with highly fenestrated
vessels (i.e. liver, spleen, lungs and bone marrow)
21. Discoidal particles have demonstrated advantages in nav-
igating and targeting the diseased vasculature, as compared to traditional spherical particles
5,15. Although some
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SCIENTIFIC REPORTS | 3 : 2079 | DOI: 10.1038/srep02079 1work has been developed on the interaction between RBCs and
micron-sized spherical beads
22–24, a comprehensive understanding
of the interplay between RBCs and NMPs, in the classical size range
for intravascular applications, has been so far overlooked.
Blood is a complex fluid comprising an aqueous solution rich in
different molecules and proteins – the plasma – and cells – RBCs,
white blood cells (WBCs) and platelets. The RBCs are the most
abundant accounting for 30 to 50% of the overall blood volume;
followed by WBCs with about 1% and platelets at percentages much
smaller than 1% of the blood volume. Because of their deformability
under flow and biconcave shape, RBCs are confined within the core
of the blood vessels and have circulation times of several weeks
25,26.
On the other hand, WBCs and platelets are required to interact
frequently with the blood vessel walls searching for vascular abnor-
malities.Indeed,thesearethefeaturesthatoptimallydesignedNMPs
should also exhibit in order to identify vascular fenestrations and
sense for the expression of disease-specific vascular receptors.
Interestingly, the RBC confinement in the vessel core regulates and
promotestheinteractionofWBCsandplateletswiththevesselwalls.
WBCs are twice as big as RBCs and are pushed laterally by the fast
moving RBCs so that WBCs can roll and eventually adhere to the
vessel walls in the inflamed microcirculation
22,23. Differently, plate-
lets are three times smaller than RBCs and, since they cannot pen-
etrate the vessel core densely packed with RBCs, are kept constantly
in close proximity of the vessel walls
27. Inspired by these two exam-
ples, delivery efficiency could be enhanced by designing NMPs that
would fully exploit the presence of RBCs in a capillary flow
24,28.
This work analyses the transport of NMPs in the microcirculation
and their interaction with circulating RBCs. The vascular radial dis-
tribution of 200 and 1,000 nm fluorescent beads is studied using
intravital video microscopy (IVM)
29 in the microcirculation of live
miceandtheImmersedFiniteElementMethod(IFEM)
30–32tomodel
the transport of NMPs in a capillary flow. Different levels of hema-
tocrit (i.e. the volume percentage of RBCs in blood) are considered
ranging from sub-physiological (0 and 15%) to physiologically rel-
evant values (30%). RBCs are treated as biconcave deformable vesi-
cles.TheNMPsaresphericalinshapeandtheirdiametervariesfrom
10 to 1,000 nm, covering the size range of interest to systemic drug
delivery and biomedical imaging systems. Finally, the radial disper-
sion of the NMPs within the capillary flow is estimated as a function
of their size and hematocrit and used as a metric for assessing the
likelihood of NMP interaction with the blood vessel walls.
Results
In vivo radial distribution of NMPs in capillary flows. Intravital
video microscopy (IVM) was used to monitor the dynamics of 200
and 1,000 nm particles in a live animal. Pegylated fluorescent
polystyrene NMPs were injected via tail vein and observed in the
microvasculature of the ear of a mouse. The IVM is constituted by a
video-rate multiphoton microscopy system that can track flowing
NMPs in the bloodstream with a frame rate at 30 Hz (Supplemen-
tary Information)
15,29. Using the video-rate acquisition, NMPs were
tracked with velocity up to ,1 mm/s which covered most capillaries
and venules in the ear. To study radial distribution of NMPs,
postcapillary venules with lumen diameter ranging from 15–30 mm
were considered.
In order to quantify the radial distribution of the circulating
NMPs, the longitudinal cross section of the blood vessel was con-
veniently divided in 5 regions: two outer layers next to the walls and
each accounting for 20% of the vessel section (0.0–0.2 and 0.8–1.0);
an inner layer whose axis coincides with that of the blood vessel,
accounting for 20% of the vessel section (0.4–0.6); and two inter-
mediatelayersextendingbetweentheouterandinnerlayersandeach
accounting for 20% of the vessel section (0.2–0.4 and 0.6–0.8). The
number of NMPs moving in each layer divided by the total number
of particles counted in the vessel gives the normalized density of
NMPs per layer. This parameter was monitored over time for each
of the 5 layers and the two different particle sizes. Fig. 1 summarizes
the findings from this in vivo analysis. The NMPs appear as yellow
dots on a red background identifying the blood vessel of interest.
Extravascular tissue showed blue fibrous structure due to second
harmonic generation signal from the collagen. The representative
IVM image of Fig. 1a shows the 200 nm NMPs distributing quite
randomly within the blood vessel without preferential accumulation
in any of the 5 layers. This is clearly reflected by the almost uniform
normalized density of NMPs over the cross section (Fig. 1b) return-
ing a value close to 0.2 for each layers. It is also demonstrated in the
SupplementaryMovieS1.Verydifferentisthebehaviorobservedfor
the 1,000 nm NMPs. These tend to mostly accumulate in the two
outer layers, next to the vessel walls (Fig. 1c and Supplementary
Figure 1 | Intravital microscopy analysis of the NMP radialdistribution. (a)Representative image of 200 nm spherical polystyrene beads (yellow dots)
in the postcapillary venule of a mouse ear. (b) Radial accumulation of the 200 nm beads presented as normalized number density. (c) Representative
image of 1,000 nm spherical polystyrene beads (yellow dots) in the postcapillary venule of a mouse ear. (d) Radial accumulation of the 1,000 nm beads
presentedasnormalized number density.(e)Trajectory and(f)radial positionof1,000 nmspherical polystyrene beads(yellowdots)inthepostcapillary
venule of a mouse ear. (bar 5 20 mm).
www.nature.com/scientificreports
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showing that ,60% of the total number of NMPs stays in the two
outer layers against a 15% of NMPs residing in the inner most layer
and the rest, 30%, in the two intermediate layers (i.e. 15% per each
intermediate layer). Thus, the larger NMPs (1,000 nm) are,3times
more concentrated near the vessel walls than the smaller NMPs
(200 nm). Fig. 1e shows a typical trajectory in vivo for the larger
1,000 nm NMP: it drifts laterally from its original position in the
vessel core to the periphery moving closer to the wall. The variation
in radial position of the NMP with time is plotted in Fig. 1f. This
shows that the lateral drift is not a continuous process: the NMP
moves laterally away from the vessel midline over the first 0.1 sec
with a velocity of ,100 mm/s; then drifts along the flow direction
longitudinally with no appreciable radial velocity for about 0.2 sec;
and, eventually, turns again towards the vessel wall rapidly moving
awayfromthe midlinewith anaveragevelocity of,11.7 mm/s.Such
a zig-zag motion with rapid changes in direction should be most
likely associated with RBC-NMP geometrical interference.
Predicting the radial transport of NMPs in a capillary flow. To
better elucidate the mechanims regulating the different NMP beha-
viors observed in the IVM experiments, a computational model is
developed within the IFEM
30–32 to analyze the size-dependent NMP
vascular transport. The dynamics of NMPs and RBCs immersed in a
bloodcapillaryisfollowedovertime,asschematicallyshownisFig.2.
The capillary is a straight tube with a diameter of 20 mm and a
parabolic velocity profile imposed at the inlet with a maximum
velocity of 100 mm/s. These are typical values for the blood flow in
the microcirculation. The vessel is filled with plasma, and RBCs are
modeled as vesicles with a hyperelastic membrane containing an
aqueous solution similar to plasma. The RBC concentration (hema-
tocrit)varies between 0 and 30%,comparable to physiological values
in the microcirculation. NMPs are considered as rigid, spherical
beads with a characteristic diameter ranging from 10 to 1,000 nm,
havingthesamedensityasplasma,toruleoutthecontributionofthe
gravitational field. The RBC-RBC and RBC- NMP interactions are
accounted for by using interaction potentials with proper coeffi-
cients, as described in the Methods and listed in Table 1. Periodic
boundary conditions are imposed at the inlet and outlet of the
capillary to limit the computational burden, while still consider-
ing sufficiently long capillaries. Therefore, RBCs and NMPs are
continuously extracted from the outlet of the vessel and re-
introduced at the inlet with the same geometric and kinematic
conditions. The total number of NMPs in the capillary is fixed for
all the simulations and it is equal to 100. The computational model
was validated using four different test cases and comparing the
numerical results with experimental data provided in the literature
(Supplementary Fig. S1). The 4 test cases are i) the analysis of RBC
stretching under uniaxial and transversal tensile forces; ii) the
computation of the discharge hematocrit out of a tube; iii) the
quantification of the apparent blood viscosity as a function of the
RBC volumetric concentration; and iv) the thickness of the cell free
layeratdifferenthematocrits.Agoodagreementisobservedbetween
the numerical predictions and the experiments, thus supporting the
accuracy and validity of the proposed approach.
The IFEM model is subsequently used to predict the dynamics of
NMPs and RBCs in a capillary flow. Representative snapshots at
different time points are presented in Fig. 3 for 100 nm NMPs. As
timeprogresses,RBCsandNMPsaretransporteddownstreambythe
flowing plasma. Note that the problem is coupled in that the fluid
velocity affects the motion of the RBCs and NMPs and vice versa,
givingafairlycomplicatedvelocityfieldinthevicinityofthedeform-
able cells and NMPs. In the initial configuration, the NMPs (yellow
dots) are randomly distributed within the capillary together with the
RBCs, occupying most of the tube volume (Fig. 3a,b). Under flow,
RBCs deform and modify locally the flow field affecting the NMP
Figure 2 | Computational domain for the capillary flow simulations. Deformable Red Blood Cells (RBCs) and spherical rigid particles are dispersed
withinanaqueoussolution(bloodplasma),fillinga20360 mmcapillary.Periodicboundaryconditionsareimposedattheinletandoutletsectionsofthe
capillary. A parabolic velocity profile is assigned at the inlet section with a maximum velocity of 100 mm/s.
Table 1 | ParametersusedintheIFEMsimulationforvasculartrans-
port
Parameter Value
Fluid density 1.0 g/cm
3
Fluid viscosity 1.2 g/(m?s)
Cytoplasm viscosity
40,41 6.0 g/(m?s)
C1 for RBC hyperelastic material
40,41 20.0 Pa
C2 for RBC hyperelastic material 1.0 Pa
De for RBC intracellular interaction 1.0 mJ/m
2
rM
0 for RBC intracellular interaction
41 0.49 mm
b for RBC intracellular interaction
41 3.84 mm
21
e for NMP interaction 1.03 10
212 J
r
LJ
0 for NMP interaction 1.0 nm
www.nature.com/scientificreports
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insets of Fig. 3 for a characteristic time running from 0.0 to 1.0 sec,
and it is also documented in the Supplementary Movies S3 and S4.
In the same snapshots the circumferential velocity profile is also
provided along the capillary with a velocity growing radially from
the periphery to the core of the channel. The RBCs deform under
flow, are pushed away from the vessel walls and tend to accumulate
within the center of the blood vessel. This leads to the formation of a
layer near the vessel wall which is depleted of RBCs (The cell-free-
layer). The thickness of the cell-free-layer varies with the hematocrit
(HCT), diameter of the capillary and mean blood velocity (Supple-
mentary Fig. S1).
Considering the same vessel partitioning (5 radial layers) intro-
duced for the IVM analysis, the normalized density of 200 and
1,000 nm NMPs is quantified within the 20 mm tube as a function
of time, at 30% hematocrit. The corresponding data are presented in
thebarchartsofFig.4at0.0,1.0,2.0and3.0 sec.Attimet50.0 sec,
the NMPs have identical volume concentrations within the 5 layers.
As time passes, the NMPs in the inner layers are pushed laterally
away from the vessel midline. For the 200 nm particles, the max-
imum normalized density is achieved in the two intermediate layers
where about 27% of the NMPs accumulate, per each layer. In the
innermost layer only 12% of the NMPs are left after 3 sec, whereas
about 17%of NMPs arefound inthe twoouterlayers, pereach layer.
For the 1,000 nm NMPs, the observed behavior is very different.
TheseNMPsaccumulateequallyintheouterandintermediatelayers
reaching a normalized density of 23% per each of the 4 layers and
leaving only a normalized density of 8% in the inner-most layer.
Although, the normalized density measured in vivo cannot be pre-
cisely recapitulated in silico, the IFEM simulations are qualitatively
in good agreement with the in vivo data. For the 1,000 nm NMPs,
most of the beads are pushed outwards radially; whereas for the
200 nm NMPs, the beads are remixed within the vessel without
showing a clear accumulation at the wall. Also, note that the overall
behavior shown within the first 1 sec of simulation is confirmed in
the following 2 sec, with slightly different values. This would imply
that1 secofsimulationissufficienttorepresenttheprocess,andthis
time period would correspond to a capillary length of ,100 mm,
given an inlet blood velocity of 100 mm/s.
It is important to emphasize that the interaction between RBCs
and NMPs is described by using a Lennard-Jones (LJ) potential (see
eq. (5) in the Methods section). Thus the charge of the NMPs is not
explicitlyconsidered,butitisratheraccountedthroughtheLJpoten-
tial strength. As such, this interaction force is proportional to the LJ
strength parameter e, varies with the separation distance r, and is
independent of theNMP size.Most importantly, this force isalready
Figure 3 | Simulated distribution of RBCs and NMPs within the capillary. (a)RBCs and (b) NMPs are randomly distributed within the capillary in the
initialconfiguration(t50 sec).(c)RepresentativeimagesshowingtheRBCandNMPdistributionwithinthecapillaryatdifferenttimepointsduringthe
simulation. The hematocrit is 30% and the number of NMPs is 100. d) The complexity of the flow field around the NMPs, in proximity of the RBCs.
www.nature.com/scientificreports
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distances larger than about r510 nm (10 times r0,with r05 1 nm).
Moreover, Fig. 3d shows the complexity of the flow field around the
NMPs, in proximity of the RBCs. The fluid velocity vector has non
zero components in the direction normal to the vessel longitudinal
axis that are responsible for pushing laterally the NMPs. This would
implythatthevasculardynamicsof theNMPsismostlygoverned by
geometrical interference and the resulting local, complex flow dyna-
mics rather than their direct repulsive interaction with the RBCs.
Radial dispersion coefficient as a function of the NMP size. Based
on the experimental evidences and the in silico data, the RBC- NMP
interaction is size-dependent. Indeed, larger NMP would interfere
more with the fast circulating RBCs; whereas small NMPs would
more easily find their way within the RBC clusters. It would then be
interesting to characterize the lateral transport of spherical beads with
varying diameters within whole blood. The dynamics of NMPs with 5
different diameters, namely 10, 50, 100, 500 and 1,000 nm, was studied
in whole blood at 30% hematocrit. Note that the vast majority of
NMPs developed for systemic drug delivery and imaging have a
diameter smaller than or close to 100 nm. The size-dependent NMP
behavior is depicted in Fig. 5 which provides the trajectories of
individual NMPs with two different initial radial positions: within
t h ec e l lf r e el a y e ra n dt h ev e s s e lc o r e .T h er e dd a s h e dl i n ei nFig. 5
identifies the cell free layer computed for the current configuration,
having a thickness of ,3.35 mm. The smallest NMPs, with a diameter
ranging from 10 to 100 nm, originally located within the vessel core,
tend to drift laterally moving towards the wall and then drifting back
towards the midline without abandoning the core (Fig. 5b–d).
Differently, larger NMPs, with a diameter ranging between 500 and
1,000 nm, tend to migrate out of the vessel core and accumulate in the
cell-free layer, as they interfere more vigorously with the fast moving
RBCs (Fig. 5e,f). On the other hand, NMPs initially located in the cell
f r e el a y e rt e n dt om o v ew i t h i nt h i sl a y e ra n do n l yt h es m a l l e rN M P s
(, 100 nm) could possibly re-enter the vessel core (Fig. 5b–f,
Supplementary Fig. S4). In order to better emphasize the role
played by RBCs, the same simulations were performed at different
hematocrits, namely 0, 15 and3 0 % ,f o rt h e1 0 0a n d1 , 0 0 0 n m
NMPs (Supplementary Figs. S2–3). As expected, in the absence of
RBCs (0% hematocrit), the NMPs follow a straight trajectory along the
streamlines with no lateral drift. Differently, at 15 and3 0 %h e m a t o c r i t ,
a lateral motion is also observed with a trajectory deviating away from
and towards the midline. The largest and more rapid fluctuations in
lateral dispersion are observed fo rt h es m a l l e rN M P s( 1 0 0n m ) ,a t1 5 %
HCT. Indeed, at lower HCT, the separation distance between adjacent
RBCs is larger and NMPs can more easily pass through the circulating
cells, thus leading to a more hectic NMP dynamics. Overall, these data
demonstrate that larger, submicron to micron-sized NMPs can be
more efficiently excluded by the vessel core, pushed laterally by the
fast moving RBCs; whereas the smallest NMPs would tend to be
confined within the vessel core and circulate for a longer time.
An effective radial dispersion coefficient can be introduced, as
defined in the Methods, to account for the radial drift of the NMPs
inthepresenceofRBCs.TheactualradialdispersioncoefficientDrof
a NMP divided by the corresponding Brownian diffusion DB is plot-
ted in Fig. 6. The radial dispersion coefficient Dr is calculated by
equation (7) in the Methods. The NMP Brownian diffusion is given
by the Stokes- Einstein relation as DB 5 kBT/3pmd, where kB is the
Boltzmann constant, T is the absolute temperature, m is the plasma
viscosity, and d is the NMP diameter. Two different particle sizes are
considered, namely 100 and 1,000 nm, at 15 and 30% HCT. The
dispersion ratio Dr/DB is higher for NMPs in the vessel core and
reduces for NMPs in the cell free layer. For the 1,000 nm, the dis-
persionratioisalwayslargerthanforthe100 nmNMPs,confirming
that the contribution of the RBCs to the dispersion of small NMPs
can be neglected. Also the average dispersion coefficient is signifi-
cantlylargerforthe15%thanfor30%HCT,butthestandarderroris
also much larger in the first case. At 15% hematocrit, this has to be
relatedtothelargerseparationdistanceamongadjacentcells.At30%
hematocrit,thedispersionratiowithinthevesselcoreisabout3times
higherthantheBrownianvalue forthe1,000 nmanditislowerthan
1 for the 100 nm. This indicates again that the larger NMPs tend to
be more vigorously pushed laterally by the moving RBCs and, thus,
have higher chances of identifying vascular abnormalities.
Discussion
The present analysis shows that sub-micron NMPs (500–1,000 nm)
onlyareefficiently pushedlaterally bythefastmovingRBCstowards
Figure 4 | Simulated radial distribution of the NMPs. The radial
accumulation of (a) 200 nm and (b) 1,000 nm NMPs within the cross
section of the capillary over time. Initially, the NMPs are equally
distributed within the five considered sectors. The hematocrit is 30% and
the number of NMPs is 100.
www.nature.com/scientificreports
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malities. This is clearly reflected in the intravital microscopy data of
Fig. 1, in the computational analysis of Fig. 4, and by the radial
dispersion coefficient data of Fig. 6. Conversely, small NMPs
(#100 nm) tend to circulate along with RBCs and interact with
thevesselwallsonlyinasmallfraction.Incidentally,thislessfrequent
interaction with the vessel walls and the lower surface of adhesion
presented by small NMPs could explain the only minimal enhance-
mentintumor accumulation often observed forbiologically targeted
NMPs
15,33.
Based on the above reasoning and the presented data, sub-micron
NMPs should be preferred for vascular targeting in that they would
interact more efficiently with the vessel walls seeking for fenestra-
tions and disease-specific vascular markers. On the other hand,
NMPs of a few tens of nanometers, and smaller, should be used for
the direct, passive targeting of diseased tissues accessible via hyper-
permeable blood vessels
34,35. Indeed, small NMPs would penetrate
deep into the malignant mass overcoming the intricate tumor extra-
cellular matrix and the adverse interstitial fluid pressure
19,20, but
would also carry a limited payload and are known to be rapidly
cleared from the circulation
36. Indeed, small NMPs would cross
unspecifically the discontinuous endothelium of major organs in
the rethiculo endothelial systems (RES), such as the liver, spleen,
and bone marrow.
In summary, one could envision the optimal delivery system for
vascular targeting as a nanoconstruct characterized by a sub-micro-
meter size, to maximize the near-wall accumulation within the cell
free layer, while still avoiding entrapment in the lungs and in small
capillaries
5; a spheroidal shape, to enhance the ligand-receptor spe-
cific interaction with the vessel walls
37 and the lateral drift within the
cell free layer towards the vessel walls
8; and surface properties sup-
porting specific vascular adhesion and reduced macrophage uptake.
Figure 5 | Analysis of the size-dependent vascular behavior of NMPs. (a) Initially, some NMPs are distributed within the cell free layer (boundary
NMPs) and other fall within the core of the capillary. Representative trajectories of NMPs with different diameters, namely (b) 10 nm; (c) 50 nm;
(d) 100 nm; (e) 500 nm; and (f) 1,000 nm. The red dashed lines identify the cell free layer. The hematocrit is 30% and the number of NMPs is 100.
Figure 6 | Radial dispersion coefficient Dr of the NMPs. The radial
dispersion coefficient is presented for the 100 nm and 1,000 nm NMPs at
two different hematocrit values, namely (a) 15% and (b) 30%. Data are
presented as absolute dispersion coefficient divided by the corresponding
Brownian diffusion coefficient.
www.nature.com/scientificreports
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In vivo intravital microscopy imaging. 8-week-old male Balb/c mice (Jackson
Laboratory) were used for the in vivo experiments. After anesthesia with
intraperitoneal injection of ketamine-xylazine (90 mg/kg and 9 mg/kg respectively),
70 kDa rhodamine dextran (3% w/v, 100 ml in saline) was injected for a clear blood
vessel demarcation .Then 200 nm and 1,000 nm spherical beads were injected
(50 ml),retro-orbitally,andtheirdynamicswasstudiedwithinthemicrocirculationof
the mouse ear. The ear of the mouse was glued on the metal plate and then placed on
thestageofthemicroscope.Forimaging,ahome-builttwo-photonmicroscopewitha
tunable Ti:Sapphire laser (Mai-Tai DeepSee, Spectra-Physics) was used. The system
employed water immersion objective lens (20X, 1.0 NA). The excitation wavelength
was set to 810 nm and power was tuned to ,25 mW at the sample. For detection,
emissions at 405 6 10 nm for second harmonic signal from the collagen, 525 6
25 nm for the microbeads, and 600 6 50 nm for vascular structure were collected by
photomultiplier tubes. All animal experiments were performed in compliance with
institutionalguidelinesandapprovedbythesubcommitteeonresearchanimalcareat
the Massachusetts General Hospital.
Preparation of the spherical beads prior injection. For in vivo circulation studies,
PEG (poly-ethylene glycol) coated polystyrene beads were used with two different
sizes, 200 nm and 1,000 nm. Amine-modified polystyrene beads were purchased
from FluoSpheres, Life Technologies. For surface pegylation, the amine-modified
beads were mixed with 20 kDa mPEG-succinimidyl valerate (Laysan Bio) in sodium
bicarbonate buffer (pH 8.4) for 3 hours and then buffer was exchanged to phosphate
buffered saline before injection.
The computational model. The Immersed Finite Element Method (IFEM)
30–32 is a
computational framework here used to simulate the transport of RBCs and NMPs
within a capillary flow. IFEM allows for the efficient analysis of multiple physical
interactions within the flow including fluid-structure interaction (FSI) between the
plasma and the deformable RBCs and NMPs; cell-cell and cell-NMP adhesive/
repulsive interactions arising at the interface between adjacent RBCs and NMPs;
Brownian diffusion; pH dependent behavior ; spontaneous self-assembly of
molecules and so on
30–32,38. In this computational framework, the cells and NMPs are
treated as Lagrangian solids immersed in an Eulerian fluid domain and the whole
transport problem is based on the solution of a Navier-Stokes equation without
requiring re-meshing as follows:
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whererfisthefluiddensity,rsisthesolid density,uisthe fluidvelocity, s
fisthe fluid
stress,s
sisthesolid stress,f
FSIistheFSIinteractionforceforIFEM,f
f
extistheexternal
forceonfluid,f
s
ext istheexternalforceonsolid,V istheentire domain including fluid
and solid domains, Vs is the solid domain and Vf is the fluid domain. The fluid in the
microvessel is considered as an incompressible viscous liquid with density 1.0 g/cm
3,
viscosity 1.2 3 10
23 Pa?s. For a detailed description of the computational model,
readers are referred to previous work
30–32,39. Briefly, the FSI forces, represented by the
termf
FSIinequations(1)and(3)arecalculatedonlyontheareaoftheimmersedsolid
element (individual cell and NMP) then, applied onto the surrounding fluid domain
using a direct forcing technique
32. The fluid domain, here representing the blood
plasma, is directly simulated using a standard fluid solver.
Interactions between immersed solids within the flow field. A Morse type
potential
31 is incorporated in IFEM scheme for describing the RBC-RBC
interaction as
WM r ðÞ ~De e
2b rM
0 {r ðÞ {2e
b rM
0 {r ðÞ
no
ð4Þ
where wM is the Morse potential, De and rM
0 are the surface energy and zero force
length, b is the scaling factor. Also, to avoid overlapping between solid bodies, a
Lennard-Jones potential is used to account for the NMP-NMP and RBC-NMP
interactions as follow
WLJ r ðÞ ~4e
r
LJ
0
r
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r
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where wLJ is the Lennard-Jones potential, e is the scaling parameter, and r
LJ
0 is the
distance for zero interaction energy. The Morse and Lennard-Jones potentials are
converted asanexternalforceterm f
s
ext
  
and includedinequation (3).Thevaluesfor
the parameters used in the present computation are listed in Table 1 and
Supplementary Table S1.
RBC constitutive relation. Thedeformation of RBCs is described by Mooney-Rivlin
material description
31 as
W~C1 J1{3 ðÞ zC2 J2{3 ðÞ ð 6Þ
where W is the elastic energy potential, C1 and C2 are the material constants, and J1
and J2 are functions of the invariants of the Cauchy–Green deformation tensor. s
s in
equation(3)iscalculated byReproducingKernelParticleMethod
39andincorporated
in a part of the f
FSI force in equation (1).
Coefficient of radial dispersion (Dr). For quantifying the radial dispersionof NMPs
with a number of particles N, the dispersion coefficient (Dr) is described as
27
Dr~
1
N
X N
i~1
ri t ðÞ {ri 0 ðÞ ðÞ
2
2t
ð7Þ
where ri(t) and ri(0) is the distance of the NMPs from the center of the channel at the
time t and the initial distance, respectively.
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